Item 2.02 Results of Operations and Financial Condition.
On August 10, 2021, Codex DNA, Inc. (the "Company") issued a press release (the
"Press Release") announcing results for the quarter ended June 30, 2021. A copy
of the Press Release is attached as Exhibit 99.1 to this current report on Form
8-K and is incorporated by reference herein.
The information under Item 2.02 in this current report on Form 8-K and the
related information in the exhibit attached hereto shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the "Exchange Act") or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, regardless of any
general incorporation language in such filing.
[[Image Removed: image.jpg]]
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release dated August 10, 2021
© Edgar Online, source Glimpses